Literature DB >> 17308854

Extended resections of liver metastases from colorectal cancer.

S Jonas1, A Thelen, C Benckert, A Spinelli, S Sammain, U Neumann, B Rudolph, P Neuhaus.   

Abstract

BACKGROUND: Indications for resection of liver metastases from colorectal cancer and surgical strategies are still under debate.
METHODS: We have retrospectively reviewed the outcome of 660 patients after 685 liver resections for metastases of colorectal cancer in our institution from 1988 to 2004. All surviving patients have a minimum follow-up period of 1 year. The longest follow-up in these patients is 16 years. Three different time periods of 5 to 6 years each were analyzed.
RESULTS: The 30- and 60-day mortality rates were 1.5% (n = 10) and 2.2 % (n = 15), respectively. The rate of formally curative (R0) resections was 84%. Five-year survival rates in all patients and in patients after R0 resection were 37% and 42%, respectively. If only resections from 1999 to 2004 were considered, 5-year survival in patients after R0 resection was 50%. In a multivariate analysis, surgical radicality, ligamental lymph node involvement, number of liver metastases, and time period, in which the liver resection had been performed, were independent prognostic parameters.
CONCLUSIONS: Outcome after liver resection for metastases from colorectal cancer has constantly improved. A formally curative resection is the most relevant prognostic parameter. Number of liver metastases and, in the few patients concerned, lymph node infiltration of the hepatoduodenal ligament, were further prognostic parameters.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17308854     DOI: 10.1007/s00268-006-0140-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  27 in total

1.  Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome.

Authors:  B Cady; R L Jenkins; G D Steele; W D Lewis; M D Stone; W V McDermott; J M Jessup; A Bothe; P Lalor; E J Lovett; P Lavin; D C Linehan
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

2.  Trends in long-term survival following liver resection for hepatic colorectal metastases.

Authors:  Michael A Choti; James V Sitzmann; Marcelo F Tiburi; Wuthi Sumetchotimetha; Ram Rangsin; Richard D Schulick; Keith D Lillemoe; Charles J Yeo; John L Cameron
Journal:  Ann Surg       Date:  2002-06       Impact factor: 12.969

3.  [Surgical resection of colorectal liver metastases: Gold standard for solitary and radically resectable lesions].

Authors:  J Scheele; A Altendorf-Hofmann; R Stangl; K Schmidt
Journal:  Swiss Surg       Date:  1996

4.  [Recurrent tumor after R0 resection of colorectal liver metastases. Incidence, resectability and prognosis].

Authors:  J Scheele; R Stangl; K Schmidt; A Altendorf-Hofmann
Journal:  Chirurg       Date:  1995-10       Impact factor: 0.955

Review 5.  Surgery for colorectal liver metastases with hepatic lymph node involvement: a systematic review.

Authors:  M S Rodgers; J L McCall
Journal:  Br J Surg       Date:  2000-09       Impact factor: 6.939

6.  [Resection of liver metastases of colorectal cancers. Results and prognostic factors].

Authors:  D Henne-Bruns; I Vogel; S Schröder; H W Schreiber; B Kremer
Journal:  Chirurg       Date:  1993-04       Impact factor: 0.955

7.  Major hepatic resection for metachronous metastases from colon cancer.

Authors:  B Cady; W V McDermott
Journal:  Ann Surg       Date:  1985-02       Impact factor: 12.969

8.  Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis.

Authors:  Christophe Laurent; Antonio Sa Cunha; Eric Rullier; Denis Smith; Anne Rullier; Jean Saric
Journal:  J Am Coll Surg       Date:  2004-06       Impact factor: 6.113

9.  Surgery for colorectal cancer metastatic to the liver. Optimizing the results of treatment.

Authors:  K Hughes; J Scheele; P H Sugarbaker
Journal:  Surg Clin North Am       Date:  1989-04       Impact factor: 2.741

10.  Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors.

Authors:  T J Gayowski; S Iwatsuki; J R Madariaga; R Selby; S Todo; W Irish; T E Starzl
Journal:  Surgery       Date:  1994-10       Impact factor: 3.982

View more
  22 in total

Review 1.  The surgical treatment of hepatic metastases in colorectal carcinoma.

Authors:  Ulf Peter Neumann; Daniel Seehofer; Peter Neuhaus
Journal:  Dtsch Arztebl Int       Date:  2010-05-14       Impact factor: 5.594

Review 2.  Oligometastatic Disease in Colorectal Cancer - How to Proceed?

Authors:  Felix Aigner; Johann Pratschke; Moritz Schmelzle
Journal:  Visc Med       Date:  2017-02-03

3.  Carcinoembryonic antigen and carbohydrate antigen 19-9 are prognostic predictors of colorectal cancer with unresectable liver metastasis.

Authors:  Yoshinobu Mitsuyama; Hiroaki Shiba; Koichiro Haruki; Yuki Fujiwara; Kenei Furukawa; Tomonori Iida; Takenori Hayashi; Masaichi Ogawa; Yuichi Ishida; Takeyuki Misawa; Hideyuki Kashiwagi; Katsuhiko Yanaga
Journal:  Oncol Lett       Date:  2012-01-18       Impact factor: 2.967

4.  [Metastatic lesions to the pancreas. When is resection reasonable?].

Authors:  M Bahra; D Jacob; J M Langrehr; M Glanemann; G Schumacher; E Lopez-Hänninen; P Neuhaus
Journal:  Chirurg       Date:  2008-03       Impact factor: 0.955

5.  Accomplishments in 2008 in the management of curable metastatic colorectal cancer.

Authors:  René Adam; Emir Hoti; Gunnar Folprecht; Al B Benson
Journal:  Gastrointest Cancer Res       Date:  2009-09

6.  Combined use of intraoperative ultrasound and indocyanine green fluorescence imaging to detect liver metastases from colorectal cancer.

Authors:  Andrea Peloso; Eloisa Franchi; Maria C Canepa; Letizia Barbieri; Laura Briani; Jacopo Ferrario; Carolina Bianco; Pietro Quaretti; Silvia Brugnatelli; Paolo Dionigi; Marcello Maestri
Journal:  HPB (Oxford)       Date:  2013-02-20       Impact factor: 3.647

7.  The Glasgow prognostic score is valuable for colorectal cancer with both synchronous and metachronous unresectable liver metastases.

Authors:  Kenei Furukawa; Hiroaki Shiba; Koichiro Haruki; Yuki Fujiwara; Tomonori Iida; Yoshinobu Mitsuyama; Masaichi Ogawa; Yuichi Ishida; Takeyuki Misawa; Katsuhiko Yanaga
Journal:  Oncol Lett       Date:  2012-05-17       Impact factor: 2.967

Review 8.  Optimal management of colorectal liver metastases in older patients: a decision analysis.

Authors:  Simon Yang; Shabbir M H Alibhai; Erin D Kennedy; Abraham El-Sedfy; Matthew Dixon; Natalie Coburn; Alex Kiss; Calvin H L Law
Journal:  HPB (Oxford)       Date:  2014-06-24       Impact factor: 3.647

9.  Accomplishments in 2007 in the management of curable metastatic colorectal cancer.

Authors:  Amit Shah; Steven Alberts; René Adam
Journal:  Gastrointest Cancer Res       Date:  2008-05

10.  Decreased levels of miR-224 and the passenger strand of miR-221 increase MBD2, suppressing maspin and promoting colorectal tumor growth and metastasis in mice.

Authors:  Kefei Yuan; Ke Xie; John Fox; Huawei Zeng; Hongwei Gao; Canhua Huang; Min Wu
Journal:  Gastroenterology       Date:  2013-06-13       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.